| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.9 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.041 |
0.9 |